SBC Medical (SBC) said Wednesday it filed a registration statement with the US Securities and Exchange Commission for the potential sale of up to $50 million of common or preferred stock from time to time.
Additionally, the company stated that its board has approved a share repurchase program of up to $20 million, which is set to terminate on December 31, 2026.